Cargando…

Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance

The purpose of this study was to identify plasma metabolites associated with superior endurance running performance. In 2016, participants at the Western States Endurance Run (WSER), a 100-mile (161-km) foot race, underwent non-targeted metabolomic testing of their post-race plasma. Metabolites asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Høeg, Tracy B., Chmiel, Kenneth, Warrick, Alexandra E., Taylor, Sandra L., Weiss, Robert H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240692/
https://www.ncbi.nlm.nih.gov/pubmed/32244618
http://dx.doi.org/10.3390/sports8040044
_version_ 1783536939462295552
author Høeg, Tracy B.
Chmiel, Kenneth
Warrick, Alexandra E.
Taylor, Sandra L.
Weiss, Robert H.
author_facet Høeg, Tracy B.
Chmiel, Kenneth
Warrick, Alexandra E.
Taylor, Sandra L.
Weiss, Robert H.
author_sort Høeg, Tracy B.
collection PubMed
description The purpose of this study was to identify plasma metabolites associated with superior endurance running performance. In 2016, participants at the Western States Endurance Run (WSER), a 100-mile (161-km) foot race, underwent non-targeted metabolomic testing of their post-race plasma. Metabolites associated with faster finish times were identified. Based on these results, runners at the 2017 WSER underwent targeted metabolomics testing, including lipidomics and choline levels. The 2017 participants’ plasma metabolites were correlated with finish times and compared with non-athletic controls. In 2016, 427 known molecules were detected using non-targeted metabolomics. Four compounds, all phosphatidylcholines (PCs) were associated with finish time (False Discovery Rate (FDR) < 0.05). All were higher in faster finishers. In 2017, using targeted PC analysis, multiple PCs, measured pre- and post-race, were higher in faster finishers (FDR < 0.05). The majority of PCs was noted to be higher in runners (both pre- and post-race) than in controls (FDR < 0.05). Runners had higher choline levels pre-race compared to controls (p < 0.0001), but choline level did not differ significantly from controls post-race (p = 0.129). Choline levels decreased between the start and the finish of the race (p < 0.0001). Faster finishers had lower choline levels than slower finishers at the race finish (p = 0.028).
format Online
Article
Text
id pubmed-7240692
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72406922020-06-11 Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance Høeg, Tracy B. Chmiel, Kenneth Warrick, Alexandra E. Taylor, Sandra L. Weiss, Robert H. Sports (Basel) Article The purpose of this study was to identify plasma metabolites associated with superior endurance running performance. In 2016, participants at the Western States Endurance Run (WSER), a 100-mile (161-km) foot race, underwent non-targeted metabolomic testing of their post-race plasma. Metabolites associated with faster finish times were identified. Based on these results, runners at the 2017 WSER underwent targeted metabolomics testing, including lipidomics and choline levels. The 2017 participants’ plasma metabolites were correlated with finish times and compared with non-athletic controls. In 2016, 427 known molecules were detected using non-targeted metabolomics. Four compounds, all phosphatidylcholines (PCs) were associated with finish time (False Discovery Rate (FDR) < 0.05). All were higher in faster finishers. In 2017, using targeted PC analysis, multiple PCs, measured pre- and post-race, were higher in faster finishers (FDR < 0.05). The majority of PCs was noted to be higher in runners (both pre- and post-race) than in controls (FDR < 0.05). Runners had higher choline levels pre-race compared to controls (p < 0.0001), but choline level did not differ significantly from controls post-race (p = 0.129). Choline levels decreased between the start and the finish of the race (p < 0.0001). Faster finishers had lower choline levels than slower finishers at the race finish (p = 0.028). MDPI 2020-04-01 /pmc/articles/PMC7240692/ /pubmed/32244618 http://dx.doi.org/10.3390/sports8040044 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Høeg, Tracy B.
Chmiel, Kenneth
Warrick, Alexandra E.
Taylor, Sandra L.
Weiss, Robert H.
Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance
title Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance
title_full Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance
title_fullStr Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance
title_full_unstemmed Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance
title_short Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance
title_sort ultramarathon plasma metabolomics: phosphatidylcholine levels associated with running performance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240692/
https://www.ncbi.nlm.nih.gov/pubmed/32244618
http://dx.doi.org/10.3390/sports8040044
work_keys_str_mv AT høegtracyb ultramarathonplasmametabolomicsphosphatidylcholinelevelsassociatedwithrunningperformance
AT chmielkenneth ultramarathonplasmametabolomicsphosphatidylcholinelevelsassociatedwithrunningperformance
AT warrickalexandrae ultramarathonplasmametabolomicsphosphatidylcholinelevelsassociatedwithrunningperformance
AT taylorsandral ultramarathonplasmametabolomicsphosphatidylcholinelevelsassociatedwithrunningperformance
AT weissroberth ultramarathonplasmametabolomicsphosphatidylcholinelevelsassociatedwithrunningperformance